- Home
- ARWR vs ASTH Comparison
ARWR vs ASTH Comparison
Compare ARWR & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- ASTH
- Stock Information
- Founded
- ARWR 2003
- ASTH 1994
- Country
- ARWR United States
- ASTH United States
- Employees
- ARWR N/A
- ASTH N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- ARWR Health Care
- ASTH Consumer Discretionary
- Exchange
- ARWR Nasdaq
- ASTH Nasdaq
- Market Cap
- ARWR 2.5B
- ASTH 1.4B
- IPO Year
- ARWR 1993
- ASTH N/A
- Fundamental
- Price
- ARWR $29.42
- ASTH $29.71
- Analyst Decision
- ARWR Strong Buy
- ASTH Strong Buy
- Analyst Count
- ARWR 8
- ASTH 8
- Target Price
- ARWR $47.75
- ASTH $53.29
- AVG Volume (30 Days)
- ARWR 2.8M
- ASTH 328.0K
- Earning Date
- ARWR 08-07-2025
- ASTH 11-06-2025
- Dividend Yield
- ARWR N/A
- ASTH N/A
- EPS Growth
- ARWR N/A
- ASTH N/A
- EPS
- ARWR N/A
- ASTH 0.52
- Revenue
- ARWR $572,976,000.00
- ASTH $2,419,115,000.00
- Revenue This Year
- ARWR $22,306.37
- ASTH $60.77
- Revenue Next Year
- ARWR N/A
- ASTH $26.90
- P/E Ratio
- ARWR N/A
- ASTH $57.99
- Revenue Growth
- ARWR 2816.20
- ASTH 51.97
- 52 Week Low
- ARWR $9.57
- ASTH $21.20
- 52 Week High
- ARWR $31.13
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- ARWR 72.20
- ASTH 52.94
- Support Level
- ARWR $28.12
- ASTH $28.48
- Resistance Level
- ARWR $31.13
- ASTH $30.55
- Average True Range (ATR)
- ARWR 1.54
- ASTH 1.17
- MACD
- ARWR 0.23
- ASTH -0.35
- Stochastic Oscillator
- ARWR 83.02
- ASTH 33.42
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.